Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov:148:104277.
doi: 10.1016/j.micpath.2020.104277. Epub 2020 May 28.

South Indian medicinal plants can combat deadly viruses along with COVID-19? - A review

Mani Divya  1 , Sekar Vijayakumar  2 , Jingdi Chen  3 , Baskaralingam Vaseeharan  4 , Esteban F Durán-Lara  5
Affiliations

South Indian medicinal plants can combat deadly viruses along with COVID-19? - A review

Mani Divya et al. Microb Pathog. 2020 Nov.

Abstract

SARS-CoV-2 is a causative agent of Coronavirus disease-19 (COVID-19), which is considered as a fatal disease for public health apprehension worldwide. This pathogenic virus can present everywhere. As it is a virus it can extend easily and cause severe illness to humans. Hence, an efficient international attentiveness of plan is necessary to cure and prevent. In this review, epidemic outbreak, clinical findings, prevention recommendations of COVID-19 and suggestive medicinal value of south Indian plant sources have been discussed. Though the varieties of improved approaches have been taken in scientific and medicinal concern, we have to pay attention to the medicinal value of the plant-based sources to prevent these types of pandemic diseases. This is one of the suggestive and effective ways to control the spreading of viruses. In the future, it is required to provide medicinal plant-based clinical products (Masks, sanitizers, soap, etc.,) with better techniques by clinicians to contend the scarcity and expose towards the nature-based medicine rather than chemical drugs. This may be a benchmark for the economical clinical trials of specific plant material to treat the viral diseases in the future.

Keywords: COVID-19; Pandemic; Prevention; South indian medicinal plants.

PubMed Disclaimer

Conflict of interest statement

Authors declares no conflict of interest.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Model structure of the nCoV.
Fig. 2
Fig. 2
Illustrative representation of the nCoV symptoms.
Fig. 3
Fig. 3
Preventive measures to stop spreading nCoV.
See this image and copyright information in PMC

References

    1. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet. Respire. Med. 2020;8:420–422. - PMC - PubMed
    1. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet. 2020;395:760–762. - PMC - PubMed
    1. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1967–1976. - PubMed
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. - PMC - PubMed
    1. Jiang S., Shi Z., Shu Y., Song J., Gao G.F., Tan W., Guo D. A distinct name is needed for the new coronavirus. Lancet. 2020;395:949. - PMC - PubMed